Search Results - "Verigou, E"

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB‐DOSE‐ADJUSTED‐EPOCH(R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL):THE GREEK EXPERIENCE ON 107 PATIENTS by Vassilakopoulos, T., Piperidou, A., Mellios, Z., Verigou, E., Kalpadakis, C., Katodritou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, C., Leonidopoulou, T., Xanthopoulos, V., Karakatsanis, S., Gainaru, G., Vrakidou, E., Koumarianou, A., Hatzimichael, E., Verrou, E., Tsirogianni, M., Drandakis, I., Lefaki, M. A., Liaskas, A., Kopsaftopoulou, A., Lampropoulou, P., Kanellias, N., Zikos, P., Liapi, D., Karianakis, G., Grentzelias, D., Papadaki, E., Siakantaris, M., Tsirigotis, P., Panitsas, F., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Skoura, E., Angelopoulou, M., Symeonidis, A., Karmiris, T., Rontogianni, P.

Get full text

P-065 Developing a flow cytometric maturation/differentiation index of the bone marrow for the diagnosis of myelodysplastic syndromes (MDS) by Verigou, E, Smyrni, N, Kolliopoulou, G, Hala, E, Lampropoulou, P, Theodorou, G, Kalogianni, F, Zikos, P, Starakis, I, Solomou, E, Karakantza, M, Symeonidis, A

Get full text

PF297 COMPARISON OF RITUXIMAB DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) WITH RITUXIMAB‐CHOP (R‐CHOP) CHEMOTHERAPY IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) by Vassilakopoulos, T., Mellios, Z., Verigou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, H., Kalpadakis, C., Gainaru, G., Karakatsanis, S., Xanthopoulos, V., Katrodritou, E., Tsirogianni, M., Arapaki, M., Giannikos, T., Katsaouni, P., Assimakopoulos, I., Liaskas, A., Constaninou, E., Bellia, M., Kourti, G., Leonidopoulou, T., Assimakopoulou, T., Karianakis, G., Symeonidis, A., Grentzelias, D., Sakellariou, K., Pappa, V., Papadaki, E., Plata, E., Bakiri, M., Angelopoulou, M., Konstantopoulos, K., Karmiris, T.

“…Background: R‐da‐EPOCH provided excellent results in PMLBCL in a phase 2 NCI trial and appeared to obviate the need for consolidative radiotherapy (RT)…”
Get full text

PS1089 PET‐SCAN FOR RESPONSE ASSESSEMENT AFTER RITUXIMAB‐DOSE‐ADJUSTED‐EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): CLINICAL AND PROGNOSTIC SIGNIFICANCE by Vassilakopoulos, T., Chatzidimitriou, C., Mellios, Z., Verigou, E., Papageorgiou, S., Giatra, H., Kalpadakis, C., Gainaru, G., Karatsanis, S., Xanthopoulos, V., Koumarianou, A., Katodritou, E., Tsirogianni, M., Arapaki, M., Giannikos, T., Efstathopoulou, M., Karanakis, G., Simeonidis, A., Grentzelias, D., Sakellariou, K., Papadaki, E., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Konstantopoulos, K., Angelopoulou, M., Themistoklis, K., Rontogianni, P.

“…Background: PET‐scan has been evaluated in PMLBCL regarding its prognostic significance under R‐CHOP and R‐MACOP‐B chemotherapy. Patients with clearly positive…”
Get full text